MedTrace Logo

Excretion of Radiolabelled AZD0837

NCT00812643 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2009-03-11

No results posted yet for this study

Summary

This is an explorative study and the scientific question to be investigated in this study is if AZD0837 and/or its metabolites AR-H069927XX and AR-H067637XX and other unknown metabolites are excreted into the bile.

Conditions

  • Healthy

Interventions

DRUG

AZD0837

Oral solution, dosing through the Loc-I-Gut catheter, single dose

Sponsors & Collaborators

Principal Investigators

  • Lars Knutson, MD, PhD · Inst för Kirurgiska VetenskaperUppsala Universitet

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Completion
2009-02-28

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00812643 on ClinicalTrials.gov